Karyopharm Therapeutics (KPTI) Q3 2023 Earnings

2NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.43
-0.38
-0.33
-0.28

Details

Expected EPS
-0.28
Actual EPS
-0.3
Surprise EPS
-0.02
Surprise Percent
+7.14%

Description

Karyopharm Therapeutics (KPTI) has reported earnings of -0.3 per share for Q3 2023.

0 Comments

Share your thoughts